Your browser doesn't support javascript.
loading
Tenofovir alone or combined with doxorubicin abrogates DMBA-induced mammary cell carcinoma: An insight into its modulatory impact on oxidative/Notch/apoptotic signaling.
Abouelezz, Hadeer M; El-Kashef, Dalia H; Abdеlaziz, Rania R; Nader, Manar A.
Afiliación
  • Abouelezz HM; Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. Electronic address: hadeer.abouelezz@mans.edu.eg.
  • El-Kashef DH; Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Abdеlaziz RR; Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Nader MA; Pharmacology and Toxicology Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Life Sci ; 326: 121798, 2023 Aug 01.
Article en En | MEDLINE | ID: mdl-37236603

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Doxorrubicina Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Life Sci Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Doxorrubicina Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Life Sci Año: 2023 Tipo del documento: Article
...